LDX Share Price Performance
AU$0.18
0.14 (300.00%)
Price AU$0.18
Share PriceAU$0.18
Lumos Diagnostics Holdings Limited's (ASX:LDX) 71% Share Price Surge Not Quite Adding Up
Aug 30
Lumos Diagnostics Holdings Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
LDX Community Narratives
There are no narratives available yet.
Recent LDX News & Updates
There's No Escaping Lumos Diagnostics Holdings Limited's (ASX:LDX) Muted Revenues Despite A 154% Share Price Rise
Jul 16Lumos Diagnostics Holdings Limited (ASX:LDX) Shares Fly 29% But Investors Aren't Buying For Growth
May 09Lacklustre Performance Is Driving Lumos Diagnostics Holdings Limited's (ASX:LDX) 29% Price Drop
Mar 07Lumos Diagnostics Holdings Limited's (ASX:LDX) Share Price Boosted 31% But Its Business Prospects Need A Lift Too
Jan 20Lumos Diagnostics Holdings Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.0091
- Gross Margin
- 61.93%
- Net Profit Margin
- -57.93%
- Debt/Equity Ratio
- 0%
Lumos Diagnostics Holdings Limited Competitors
Snowflake Analysis
About LDX
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
U.S. Market Performance
- 7 Days: 0.3%
- 3 Months: 8.5%
- 1 Year: 17.3%
- Year to Date: 15.0%
The market has stayed flat over the 7 days. More promisingly, the market is up 17% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›